Global Molecular Theranostics Market Growth (Status and Outlook) 2026-2032

August 2026 | 84 pages | ID: GD722807FBDEEN
LP Information

Abstracts

The global Molecular Theranostics market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Molecular theranostics can be described as a system that integrates a diagnostic test with a therapeutic intervention targeting a molecular feature of disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Molecular Theranostics Industry Forecast” looks at past sales and reviews total world Molecular Theranostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Theranostics sales for 2026 through 2032. With Molecular Theranostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Theranostics industry.

This Insight Report provides a comprehensive analysis of the global Molecular Theranostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Theranostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Theranostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Theranostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Theranostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Theranostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Amplification Theranostics
• Amplified Gene Detection Theranostics
• Oligonucleotide Microarrays
• Gene Sequencing

Segmentation by Application:

• Hospitals and Clinics
• Research Institutes
• Diagnostic Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Abbott
• BD
• Biomerieux
• Qiagen
• Thermo Fisher Scientific
• Agilent
• GenMark
• Siemens Healthcare
• AutoGenomics

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Molecular Theranostics Market Size (2021-2032)
  2.1.2 Molecular Theranostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Molecular Theranostics by Country/Region (2021, 2025 & 2032)
  2.2 Molecular Theranostics Segment by Type
  2.2.1 Amplification Theranostics
  2.2.2 Amplified Gene Detection Theranostics
  2.2.3 Oligonucleotide Microarrays
  2.2.4 Gene Sequencing
  2.2.5 Molecular Theranostics Market Size by Type
  2.2.5.1 Molecular Theranostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
  2.2.5.2 Global Molecular Theranostics Market Size Market Share by Type (2021-2026)
  2.3 Molecular Theranostics Segment by Application
  2.3.1 Hospitals and Clinics
  2.3.2 Research Institutes
  2.3.3 Diagnostic Centers
  2.3.4 Others
  2.3.5 Molecular Theranostics Market Size by Application
  2.3.5.1 Molecular Theranostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
  2.3.5.2 Global Molecular Theranostics Market Size Market Share by Application (2021-2026)

3 MOLECULAR THERANOSTICS MARKET SIZE BY PLAYER

  3.1 Molecular Theranostics Market Size Market Share by Player
  3.1.1 Global Molecular Theranostics Revenue by Player (2021-2026)
  3.1.2 Global Molecular Theranostics Revenue Market Share by Player (2021-2026)
  3.2 Global Molecular Theranostics Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 MOLECULAR THERANOSTICS BY REGION

  4.1 Molecular Theranostics Market Size by Region (2021-2026)
  4.2 Global Molecular Theranostics Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Molecular Theranostics Market Size Growth (2021-2026)
  4.4 APAC Molecular Theranostics Market Size Growth (2021-2026)
  4.5 Europe Molecular Theranostics Market Size Growth (2021-2026)
  4.6 Middle East & Africa Molecular Theranostics Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Molecular Theranostics Market Size by Country (2021-2026)
  5.2 Americas Molecular Theranostics Market Size by Type (2021-2026)
  5.3 Americas Molecular Theranostics Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Molecular Theranostics Market Size by Region (2021-2026)
  6.2 APAC Molecular Theranostics Market Size by Type (2021-2026)
  6.3 APAC Molecular Theranostics Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Molecular Theranostics Market Size by Country (2021-2026)
  7.2 Europe Molecular Theranostics Market Size by Type (2021-2026)
  7.3 Europe Molecular Theranostics Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Molecular Theranostics by Region (2021-2026)
  8.2 Middle East & Africa Molecular Theranostics Market Size by Type (2021-2026)
  8.3 Middle East & Africa Molecular Theranostics Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL MOLECULAR THERANOSTICS MARKET FORECAST

  10.1 Global Molecular Theranostics Forecast by Region (2027-2032)
  10.1.1 Global Molecular Theranostics Forecast by Region (2027-2032)
  10.1.2 Americas Molecular Theranostics Forecast
  10.1.3 APAC Molecular Theranostics Forecast
  10.1.4 Europe Molecular Theranostics Forecast
  10.1.5 Middle East & Africa Molecular Theranostics Forecast
  10.2 Americas Molecular Theranostics Forecast by Country (2027-2032)
  10.2.1 United States Market Molecular Theranostics Forecast
  10.2.2 Canada Market Molecular Theranostics Forecast
  10.2.3 Mexico Market Molecular Theranostics Forecast
  10.2.4 Brazil Market Molecular Theranostics Forecast
  10.3 APAC Molecular Theranostics Forecast by Region (2027-2032)
  10.3.1 China Molecular Theranostics Market Forecast
  10.3.2 Japan Market Molecular Theranostics Forecast
  10.3.3 Korea Market Molecular Theranostics Forecast
  10.3.4 Southeast Asia Market Molecular Theranostics Forecast
  10.3.5 India Market Molecular Theranostics Forecast
  10.3.6 Australia Market Molecular Theranostics Forecast
  10.4 Europe Molecular Theranostics Forecast by Country (2027-2032)
  10.4.1 Germany Market Molecular Theranostics Forecast
  10.4.2 France Market Molecular Theranostics Forecast
  10.4.3 UK Market Molecular Theranostics Forecast
  10.4.4 Italy Market Molecular Theranostics Forecast
  10.4.5 Russia Market Molecular Theranostics Forecast
  10.5 Middle East & Africa Molecular Theranostics Forecast by Region (2027-2032)
  10.5.1 Egypt Market Molecular Theranostics Forecast
  10.5.2 South Africa Market Molecular Theranostics Forecast
  10.5.3 Israel Market Molecular Theranostics Forecast
  10.5.4 Turkey Market Molecular Theranostics Forecast
  10.6 Global Molecular Theranostics Forecast by Type (2027-2032)
  10.7 Global Molecular Theranostics Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Molecular Theranostics Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Molecular Theranostics Product Offered
  11.1.3 Roche Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
  11.2 Abbott
  11.2.1 Abbott Company Information
  11.2.2 Abbott Molecular Theranostics Product Offered
  11.2.3 Abbott Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott Latest Developments
  11.3 BD
  11.3.1 BD Company Information
  11.3.2 BD Molecular Theranostics Product Offered
  11.3.3 BD Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 BD Main Business Overview
  11.3.5 BD Latest Developments
  11.4 Biomerieux
  11.4.1 Biomerieux Company Information
  11.4.2 Biomerieux Molecular Theranostics Product Offered
  11.4.3 Biomerieux Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Biomerieux Main Business Overview
  11.4.5 Biomerieux Latest Developments
  11.5 Qiagen
  11.5.1 Qiagen Company Information
  11.5.2 Qiagen Molecular Theranostics Product Offered
  11.5.3 Qiagen Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Qiagen Main Business Overview
  11.5.5 Qiagen Latest Developments
  11.6 Thermo Fisher Scientific
  11.6.1 Thermo Fisher Scientific Company Information
  11.6.2 Thermo Fisher Scientific Molecular Theranostics Product Offered
  11.6.3 Thermo Fisher Scientific Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Thermo Fisher Scientific Main Business Overview
  11.6.5 Thermo Fisher Scientific Latest Developments
  11.7 Agilent
  11.7.1 Agilent Company Information
  11.7.2 Agilent Molecular Theranostics Product Offered
  11.7.3 Agilent Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Agilent Main Business Overview
  11.7.5 Agilent Latest Developments
  11.8 GenMark
  11.8.1 GenMark Company Information
  11.8.2 GenMark Molecular Theranostics Product Offered
  11.8.3 GenMark Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 GenMark Main Business Overview
  11.8.5 GenMark Latest Developments
  11.9 Siemens Healthcare
  11.9.1 Siemens Healthcare Company Information
  11.9.2 Siemens Healthcare Molecular Theranostics Product Offered
  11.9.3 Siemens Healthcare Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Siemens Healthcare Main Business Overview
  11.9.5 Siemens Healthcare Latest Developments
  11.10 AutoGenomics
  11.10.1 AutoGenomics Company Information
  11.10.2 AutoGenomics Molecular Theranostics Product Offered
  11.10.3 AutoGenomics Molecular Theranostics Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 AutoGenomics Main Business Overview
  11.10.5 AutoGenomics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Molecular Theranostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Theranostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Amplification Theranostics
Table 4. Major Players of Amplified Gene Detection Theranostics
Table 5. Major Players of Oligonucleotide Microarrays
Table 6. Major Players of Gene Sequencing
Table 7. Molecular Theranostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Molecular Theranostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Molecular Theranostics Market Size Market Share by Type (2021-2026)
Table 10. Molecular Theranostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Molecular Theranostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Molecular Theranostics Market Size Market Share by Application (2021-2026)
Table 13. Global Molecular Theranostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Molecular Theranostics Revenue Market Share by Player (2021-2026)
Table 15. Molecular Theranostics Key Players Head office and Products Offered
Table 16. Molecular Theranostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Molecular Theranostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Molecular Theranostics Market Size Market Share by Region (2021-2026)
Table 21. Global Molecular Theranostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Molecular Theranostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Molecular Theranostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Molecular Theranostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Molecular Theranostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Molecular Theranostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Molecular Theranostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Molecular Theranostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Molecular Theranostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Molecular Theranostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Molecular Theranostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Molecular Theranostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Molecular Theranostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Molecular Theranostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Molecular Theranostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Molecular Theranostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Molecular Theranostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Theranostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Molecular Theranostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Molecular Theranostics
Table 41. Key Market Challenges & Risks of Molecular Theranostics
Table 42. Key Industry Trends of Molecular Theranostics
Table 43. Global Molecular Theranostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Molecular Theranostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Molecular Theranostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Molecular Theranostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Roche Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 48. Roche Molecular Theranostics Product Offered
Table 49. Roche Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Roche Main Business
Table 51. Roche Latest Developments
Table 52. Abbott Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 53. Abbott Molecular Theranostics Product Offered
Table 54. Abbott Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. BD Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 58. BD Molecular Theranostics Product Offered
Table 59. BD Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. BD Main Business
Table 61. BD Latest Developments
Table 62. Biomerieux Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 63. Biomerieux Molecular Theranostics Product Offered
Table 64. Biomerieux Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Biomerieux Main Business
Table 66. Biomerieux Latest Developments
Table 67. Qiagen Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 68. Qiagen Molecular Theranostics Product Offered
Table 69. Qiagen Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Qiagen Main Business
Table 71. Qiagen Latest Developments
Table 72. Thermo Fisher Scientific Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 73. Thermo Fisher Scientific Molecular Theranostics Product Offered
Table 74. Thermo Fisher Scientific Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific Latest Developments
Table 77. Agilent Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 78. Agilent Molecular Theranostics Product Offered
Table 79. Agilent Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Agilent Main Business
Table 81. Agilent Latest Developments
Table 82. GenMark Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 83. GenMark Molecular Theranostics Product Offered
Table 84. GenMark Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. GenMark Main Business
Table 86. GenMark Latest Developments
Table 87. Siemens Healthcare Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 88. Siemens Healthcare Molecular Theranostics Product Offered
Table 89. Siemens Healthcare Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Siemens Healthcare Main Business
Table 91. Siemens Healthcare Latest Developments
Table 92. AutoGenomics Details, Company Type, Molecular Theranostics Area Served and Its Competitors
Table 93. AutoGenomics Molecular Theranostics Product Offered
Table 94. AutoGenomics Molecular Theranostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. AutoGenomics Main Business
Table 96. AutoGenomics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Theranostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Theranostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Theranostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Theranostics Sales Market Share by Country/Region (2025)
Figure 8. Molecular Theranostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Theranostics Market Size Market Share by Type in 2025
Figure 10. Molecular Theranostics in Hospitals and Clinics
Figure 11. Global Molecular Theranostics Market: Hospitals and Clinics (2021-2026) & ($ millions)
Figure 12. Molecular Theranostics in Research Institutes
Figure 13. Global Molecular Theranostics Market: Research Institutes (2021-2026) & ($ millions)
Figure 14. Molecular Theranostics in Diagnostic Centers
Figure 15. Global Molecular Theranostics Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 16. Molecular Theranostics in Others
Figure 17. Global Molecular Theranostics Market: Others (2021-2026) & ($ millions)
Figure 18. Global Molecular Theranostics Market Size Market Share by Application in 2025
Figure 19. Global Molecular Theranostics Revenue Market Share by Player in 2025
Figure 20. Global Molecular Theranostics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Molecular Theranostics Market Size 2021-2026 ($ millions)
Figure 22. APAC Molecular Theranostics Market Size 2021-2026 ($ millions)
Figure 23. Europe Molecular Theranostics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Molecular Theranostics Market Size 2021-2026 ($ millions)
Figure 25. Americas Molecular Theranostics Value Market Share by Country in 2025
Figure 26. United States Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Molecular Theranostics Market Size Market Share by Region in 2025
Figure 31. APAC Molecular Theranostics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Molecular Theranostics Market Size Market Share by Application (2021-2026)
Figure 33. China Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Molecular Theranostics Market Size Market Share by Country in 2025
Figure 40. Europe Molecular Theranostics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Molecular Theranostics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Molecular Theranostics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Molecular Theranostics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Molecular Theranostics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Molecular Theranostics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 56. APAC Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 57. Europe Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 59. United States Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 60. Canada Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 63. China Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 64. Japan Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 65. Korea Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 67. India Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 68. Australia Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 69. Germany Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 70. France Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 71. UK Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 72. Italy Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 73. Russia Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 76. Israel Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Molecular Theranostics Market Size 2027-2032 ($ millions)
Figure 78. Global Molecular Theranostics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Molecular Theranostics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Molecular Theranostics Market Size 2027-2032 ($ millions)